<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>TABLE 1</label>
 <caption>
  <p>Approved and experimental antiviral drugs against HSV-1 and HSV-2 (non-botanical).</p>
 </caption>
 <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
  <thead>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Drug</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Mechanism of action</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Type of molecule</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Status</td>
    <td valign="top" align="left" rowspan="1" colspan="1">References</td>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Acyclovir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleoside analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B65" ref-type="bibr">Gnann et al., 1983</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Valacyclovir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleoside analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B167" ref-type="bibr">Schuster et al., 2016</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Penciclovir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleoside analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B128" ref-type="bibr">Meira et al., 2019</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Famciclovir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleoside analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B133" ref-type="bibr">Mondal, 2007</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Ganciclovir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleoside analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B3" ref-type="bibr">Al-Badr and Ajarim, 2018</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Foscarnet</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Pyrophosphate analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B40" ref-type="bibr">Crumpacker, 1992</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Cidofovir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleotide analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B100" ref-type="bibr">Lea and Bryson, 1996</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Docosanol</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Viral entry inhibitor</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Saturated alcohol</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B190" ref-type="bibr">Treister and Woo, 2010</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Benzalkonium chloride</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Virucidal</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Alkylamine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Stand-by in the United States</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B186" ref-type="bibr">Taylor-Robinson and Ballard, 2001</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Idoxuridine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Deoxyuridine analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B36" ref-type="bibr">Chou and Hong, 2014; Wilhelmus</xref>, 
     <xref rid="B200" ref-type="bibr">2015</xref>; 
     <xref rid="B44" ref-type="bibr">De Clercq and Li, 2016</xref>; 
     <xref rid="B158" ref-type="bibr">Roozbahani and Hammersmith, 2018</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Vidarabine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleoside analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B36" ref-type="bibr">Chou and Hong, 2014</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Trifluridine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleoside analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by FDA and EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B200" ref-type="bibr">Wilhelmus, 2015</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Brivudine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleoside analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Approved by EMA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B43" ref-type="bibr">De Clercq, 2019</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Brincidofovir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Nucleotide analog</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Under FDA Review</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B107" ref-type="bibr">Lee et al., 2018</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Amenamevir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Helicase-Primase inhibitor</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Being assessed in clinical trials</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B90" ref-type="bibr">Kawashima et al., 2017</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Pritelivir</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibitor of viral DNA replication</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Helicase-Primase inhibitor</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Being assessed in clinical trials</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B196" ref-type="bibr">Wald et al., 2014</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Nelfinavir mesylate</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inhibits the maturation and export of viral particles</td>
    <td valign="top" align="left" rowspan="1" colspan="1">HIV-1 protease inhibitor</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Being assessed in clinical trials for HSV</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B87" ref-type="bibr">Kalu et al., 2014</xref>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
